Fish Poison Tree

Barringtonia asiatica seeds and bark contain tannins, saponins, flavonoids, terpenoids, and the oleanane glycoside ranuncoside, which collectively confer antioxidant, antimicrobial, and piscicidal activities through phenolic free-radical scavenging, membrane disruption, and concentration-dependent cytotoxicity. Stem-bark chloroform fractions demonstrate the strongest documented bioactivity, with an antioxidant IC50 of 34.46 ± 0.32 μg/mL and a cytotoxic LC50 of 34.059 μg/mL in brine shrimp assays, though all evidence remains preclinical and no human clinical trials have been conducted.

Origin & History

Barringtonia asiatica is native to the coastal regions of the Indo-Pacific, spanning the Pacific Islands, Southeast Asia, South Asia, and coastal East Africa, where it thrives in mangrove margins, sandy beaches, and tropical littoral forests. The tree is commonly found growing along shorelines and tidal zones in Melanesia, Polynesia, the Philippines, India, and Sri Lanka, tolerating saline soils and high humidity. It has been cultivated and naturalized across tropical regions where traditional communities have long harvested its large, corky seeds, fruits, leaves, and bark for medicinal and subsistence purposes.

Historical & Cultural Context

Barringtonia asiatica holds deep cultural significance across Melanesia, Polynesia, and coastal Asia, where communities have long recognized it as the 'fish poison tree' due to the practice of crushing seeds and casting them into water to stun fish for easy harvesting—a technique documented across Pacific Island and Southeast Asian fishing cultures for centuries. In Melanesian healing traditions, seeds are prepared as topical poultices for wound care, leveraging the plant's astringent and antimicrobial properties in environments where modern antiseptics were historically unavailable. Across India, China, and Southeast Asia, bark and leaf preparations have been incorporated into traditional medical systems to address liver disorders, eye diseases, diarrhea, and fungal skin infections, with methods ranging from bark decoctions to leaf compresses. The tree also carries spiritual and practical significance in many Pacific Island communities, planted near settlements both for medicinal access and as a coastal windbreak, reflecting its integration into both material and symbolic cultural life.

Health Benefits

- **Antioxidant Activity**: Phenolic and flavonoid compounds in stem-bark and leaf extracts scavenge free radicals, with the stem-bark chloroform fraction achieving an IC50 of 34.46 ± 0.32 μg/mL and methanol leaf extract IC50 of 125.87 ppm in DPPH assays, suggesting dose-dependent radical neutralization capacity.
- **Antimicrobial Effects**: Extracts from leaves and bark show inhibitory activity against both Gram-positive bacteria (Staphylococcus aureus) and Gram-negative species (Escherichia coli, Salmonella typhi, Klebsiella pneumoniae), with select fractions producing inhibition zones of 18–20 mm in disc diffusion assays, likely mediated by saponins, tannins, and terpenoids disrupting bacterial membranes.
- **Wound Healing Support**: In Melanesian traditional medicine, crushed seeds are applied topically to wounds, with antimicrobial and tannin-mediated astringent properties providing a plausible biological basis for tissue protection and infection prevention, though no controlled wound-healing trials have been performed.
- **Cytotoxic Potential**: Stem-bark extracts exhibit concentration-dependent cytotoxicity with an LC50 of 34.059 μg/mL in the brine shrimp lethality assay, indicating general bioactive potency that warrants further investigation for anticancer applications, though specific mechanistic pathways and mammalian cell data remain limited.
- **Antifungal Properties**: Traditional use for antifungal treatments across Asia and Africa is supported by phytochemical composition rich in terpenoids and saponins, which are recognized classes of antifungal agents capable of disrupting fungal cell membranes, although controlled mycological studies on B. asiatica specifically are scarce.
- **Hepatoprotective Traditional Use**: Bark and leaf preparations have been used across traditional systems in India, China, and Southeast Asia for liver disorders, with flavonoids and tannins providing a plausible hepatoprotective basis through reduction of oxidative stress and hepatocellular inflammation, pending formal hepatological studies.
- **Anti-diarrheal Activity**: Traditional use for diarrheal disease is consistent with the astringent properties of high tannin content in bark and leaf extracts, which can reduce intestinal motility and inhibit enteropathogens such as E. coli and Salmonella typhi, as suggested by in vitro antimicrobial data.

How It Works

The antioxidant mechanism of Barringtonia asiatica is primarily attributed to polyphenolic compounds—flavonoids and tannins—that donate hydrogen atoms to neutralize reactive oxygen species, as quantified by DPPH radical scavenging assays across multiple extract fractions. Antimicrobial activity against both Gram-positive and Gram-negative bacteria is mechanistically linked to saponins, which intercalate into phospholipid bilayers and increase membrane permeability, and to tannins, which complex with cell-surface proteins and inhibit bacterial adhesion and enzymatic function. The oleanane glycoside ranuncoside, concentrated in seeds, is responsible for piscicidal activity through disruption of gill membrane ion transport in fish, and this general cytotoxic mechanism may underlie the broader concentration-dependent cytotoxicity observed in brine shrimp bioassays. Essential oil components identified in leaf hydrodistillates—including uncineol (30.9%), eicosane (27.4%), and 4-propyl-guaiacol (14.05%)—may contribute to membrane-active antimicrobial effects, though specific molecular receptor interactions and intracellular signaling pathway data for any constituent have not been characterized in published studies.

Scientific Research

The existing evidence base for Barringtonia asiatica consists entirely of in vitro phytochemical and bioassay studies, with no peer-reviewed human clinical trials or animal pharmacological trials identified in the available literature. Antimicrobial investigations have employed disc diffusion assays against standard bacterial strains, reporting inhibition zones of 2.50 ± 0.10 to 5.00 ± 0.06 mm for dichloromethane leaf extracts and 18–20 mm for select concentrated fractions, though these values remain below or marginally comparable to tetracycline controls and lack minimum inhibitory concentration (MIC) validation. Cytotoxicity has been assessed using the brine shrimp lethality assay with a sample size of n=30, yielding LC50 values of 34.059 μg/mL for stem-bark extracts—a widely used but crude proxy for anticancer potential that does not predict human therapeutic efficacy. Overall evidence quality is very low by clinical standards, with no randomized controlled trials, no pharmacokinetic studies, no standardized extract formulations, and no safety evaluations in human populations.

Clinical Summary

No human clinical trials have been conducted on Barringtonia asiatica for any indication, including wound healing, antimicrobial infection treatment, liver disease, or cancer. All available quantitative data derive from in vitro assays—primarily DPPH antioxidant assays, disc diffusion antimicrobial tests, and brine shrimp lethality assays—which provide preliminary biological plausibility but cannot be directly extrapolated to clinical efficacy or safety in humans. The most robust preclinical finding is the stem-bark chloroform fraction antioxidant IC50 of 34.46 ± 0.32 μg/mL, which indicates meaningful radical-scavenging capacity in cell-free systems, but bioavailability, metabolic transformation, and therapeutic dosing in vivo remain entirely uninvestigated. Confidence in any therapeutic claim for this plant is therefore very low, and it should be considered a candidate for future pharmacological and ethnobotanical research rather than a validated clinical ingredient.

Nutritional Profile

Barringtonia asiatica is not consumed as a food source due to the toxicity of its seeds and the bitter, astringent quality of its bark and leaves, and consequently no formal nutritional macronutrient or micronutrient profile has been characterized. Phytochemically, all plant parts contain tannins, saponins, alkaloids, steroids, phenols, flavonoids, terpenoids, and glycosides, with the oleanane glycoside ranuncoside identified as a primary bioactive constituent of seeds responsible for piscicidal activity. Leaf essential oil composition has been quantified at uncineol (30.9%), eicosane (27.4%), and 4-propyl-guaiacol (14.05%) by GC analysis, representing the most precise phytochemical concentration data available. Bioavailability of any constituent following oral or topical exposure in humans has not been studied, and the cytotoxic potential of seed extracts at moderate concentrations precludes nutritional supplementation without further safety characterization.

Preparation & Dosage

- **Traditional Topical Application (Seeds)**: Melanesian traditions use crushed or macerated seeds applied directly to wounds as a poultice; no standardized weight or frequency is documented.
- **Methanol Leaf Extract (Research Use Only)**: Used at concentrations of 25–100 μg/mL in in vitro antioxidant assays; not suitable for human consumption in this form.
- **Stem-Bark Chloroform Fraction (Research Use Only)**: Active at 34.46 μg/mL in DPPH assays and 34.059 μg/mL LC50 in cytotoxicity bioassays; no human dose established.
- **Leaf Essential Oil (Hydrodistillation)**: Prepared by steam or hydrodistillation of fresh or dried leaves; composition includes uncineol (30.9%), eicosane (27.4%), and 4-propyl-guaiacol (14.05%); therapeutic dose for humans is undefined.
- **Bark Decoction (Traditional)**: Used historically in Asia and the Pacific Islands for liver and gastrointestinal complaints via hot-water extraction of dried bark; no standardized preparation, concentration, or dosage regimen is established.
- **Note**: No commercial supplement forms (capsules, tablets, standardized extracts) are currently documented. All dosage forms referenced in research literature are experimental and intended solely for laboratory bioassays.

Synergy & Pairings

No formal synergy studies have been conducted for Barringtonia asiatica in combination with other ingredients, and no evidence-based stack pairings exist in the published literature. Theoretically, the tannin and flavonoid content could complement other polyphenol-rich botanicals such as green tea extract (Camellia sinensis) in antioxidant applications, as both contribute phenolic radical scavenging through overlapping but structurally distinct mechanisms. Similarly, the saponin-mediated antimicrobial activity of B. asiatica extracts might be pharmacologically additive with other membrane-disrupting antimicrobial agents such as tea tree oil (Melaleuca alternifolia), though this combination has not been empirically tested.

Safety & Interactions

Safety data for Barringtonia asiatica in humans is essentially absent from the scientific literature; the only quantitative toxicity metric is a brine shrimp lethality LC50 of 34.059 μg/mL for stem-bark chloroform extract, indicating moderate cytotoxic potential in this invertebrate model that cannot be directly translated to human risk thresholds. The seeds in particular are recognized as toxic due to ranuncoside and other saponins, and are deliberately used as fish poisons, strongly contraindicating internal consumption without rigorous safety evaluation. No drug interaction data exist, though the high tannin content in bark extracts could theoretically reduce oral absorption of coadministered medications—particularly antibiotics, iron supplements, and alkaloid-based drugs—by forming insoluble complexes in the gastrointestinal tract. Pregnancy, lactation, and pediatric use are entirely contraindicated given the absence of safety data and the demonstrated cytotoxic bioactivity; no maximum safe dose for any plant part or extract has been established for human use.